Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, Beigene, Deciphera, Generex, Immuron, IMV, Puma, Redhill, Shanghai Fosun, Sorrento, Specialised, Tetra.